Ever since Congress passed the Dodd-Frank Wall Street Reform and Consumer Protection Act, otherwise known as “Dodd-Frank”, a robust set of remedies and statutes preventing employer retaliation are now in place. For example, under Dodd-Frank, The Securities and Exchange Commission (SEC) and Commodities Futures Trading Commission (CFTC) are both authorized to provide a monetary award–ranging between 10% to 30% of the money collected–to anyone who comes forward with high-quality information that leads to an enforcement action in which sanctions exceed $1 million dollars.
Moreover, the Anti-Money Laundering Act of 2020 directs the Department of Treasury’s Financial Crimes Enforcement Network (FinCEN) to establish a new whistleblower program. The new program removes the previous $150,000 cap on awards to potential whistleblowers and directs the Treasury to award up to 30% of the money collected by the department.
The Dilendorf Law Firm has strong relationships and will work in concert with the federal agencies responsible for regulating the crypto field. Moreover, our attorneys are well-versed in the many federal whistleblower programs created by the Dodd-Frank Act. Our attorneys will leverage this expertise and will work together with our clients to ensure they feel safe and protected throughout the process.
Many of the clients we represent are using Dodd-Frank protections to report the following:
- Violations of securities laws
- Violations of laws governing the Commodities Futures Trading Commission
- Violations of the Foreign Corrupt Practices Act
- These may include crimes such as broker fraud, insider trading, corporate bribery and fraud, and market manipulation.
Our firm is equipped to provide the best possible representation for anyone considering blowing the whistle on a company involved in the crypto, blockchain, and fintech industries, including but not limited to:
- Digital Asset Exchanges
- Decentralized Finance Platforms
- Online Trading Platforms
- Decentralized Applications
- Liquidity Pool Providers
- Token and NFT Issuers
- Wallet Providers
The Dilendorf Law Firm ensures that all claims are filed correctly and with the appropriate parties while protecting the privacy of our clients. Our experienced team has an excellent track record of working with various government agencies while protecting clients from employer retaliation.
Track Record of our Excellent Strategic Co-Counsels – Adam Pollock and Steve Cohen
A healthcare provider paid $195 million to settle allegations that the company encouraged physicians to prescribe highly addictive opioid painkillers for unapproved purposes. (The painkillers were approved for cancer patients only, but the company was encouraging prescriptions for non-cancer patients.)
A company paid $500 million to resolve various claims including that it promoted the use of its drug product to physicians who “were writing prescriptions … that were unsafe, ineffective, and medically unnecessary.”
A healthcare operator paid $48 million to resolve allegations that some patient admissions to its facilities were not medically necessary and that some of its facilities provided inaccurate information to Medicare to maintain their status as “inpatient rehabilitation facilities” – a designation that enabled the operator to earn a higher rate of reimbursement from Medicare.
A medical device manufacturer paid $33.2 million to resolve allegations that it sold a materially unreliable testing device that was intended to help doctors and nurses diagnose drug overdoses, assess acute coronary syndrome, and identify other serious conditions
A major hospital system paid $731 million to resolve claims that it ordered medical tests that were not necessary, up-coded various charges, and misrepresented its advertising expenses as “community education” in order to get the government to pay for non-reimbursable expenses.
The most common types of healthcare fraud include:
A major pharmaceutical company paid $3 billion to resolve charges that it illegally promoted nine different prescription drugs, paid kickbacks to doctors to prescribe the medications, and falsified scientific research and articles.
Recent SEC Public Whistleblower Awards:
Recent CFTC Public Whistleblower Awards: